Minerva Neurosciences, Inc. — Earnings Release 2014

Aug 7, 2014

8-K 1 a14-18625_18k.htm 8-K

*UNITED STATES*

*SECURITIES AND EXCHANGE COMMISSION*

*Washington, D.C. 20549*

*FORM 8-K*

*CURRENT REPORT*

*Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934*

Date of report (Date of earliest event reported): *August 7, 2014*

*MINERVA NEUROSCIENCES, INC.*

(Exact name of registrant as specified in its charter)

Delaware	001-36517	26-0784194
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

*245 First Street*

*Suite 1800*

*Cambridge, MA*

*02142*

(Address of principal executive offices)

Registrant’s telephone number, including area code: (617) 444-8444

*Not Applicable*

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

SEQ.=1,FOLIO='',FILE='C:\JMS\108646\14-18625-1\task6916901\18625-1-ba.htm',USER='108646',CD='Aug 7 18:29 2014'

*Item 2.02. Results of Operations and Financial Condition.*

On August 7, 2014, Minerva Neurosciences, Inc. issued a press release announcing its preliminary summary unaudited condensed consolidated financial results for the period ended June 30, 2014. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated by reference herein.

The information in this Current Report, including the accompanying exhibit, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing.

*Item 9.01 Financial Statements and Exhibits.*

(d) Exhibits

Exhibit No.	Description
99.1	Press Release dated August 7, 2014

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\108646\14-18625-1\task6916901\18625-1-ba.htm',USER='108646',CD='Aug 7 18:29 2014'

*SIGNATURE*

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: August 7, 2014

MINERVA NEUROSCIENCES, INC.,
a Delaware corporation
By:	/s/ Rogerio Vivaldi Coelho
Name:	Rogerio Vivaldi Coelho MD, MBA
Title:	President, Chief Executive Officer and Director

3

SEQ.=1,FOLIO='3',FILE='C:\JMS\108646\14-18625-1\task6916901\18625-1-ba.htm',USER='108646',CD='Aug 7 18:29 2014'

*EXHIBIT INDEX*

Exhibit No.	Description
99.1	Press Release dated August 7, 2014

4

SEQ.=1,FOLIO='4',FILE='C:\JMS\108646\14-18625-1\task6916901\18625-1-ba.htm',USER='108646',CD='Aug 7 18:29 2014'